Arteriolar Involvement in the Microvascular Lesions of Diabetic Retinopathy: Implications for Pathogenesis

REFERENCES

• Akagi Y, Kador P F, Kuwabara T, Kinoshita J H. Aldose reductase localization in human retinal mural cells. Invest Ophthalmol Vis Sci 1983; 24: 1516–1519
   PubMed Web of Science ®Google Scholar
• Alder V A, Su E N, Yu D Y, Cringle S, Yu P. Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy. Aust N Z J Ophthalmol 1998; 26: 141–148
   Google Scholar
• Amemiya T, Bhutto I A. Retinal vascular changes and systemic diseases: corrosion cast demonstration. Ital J Anat Embryol 2001; 106: 237–244
   Google Scholar
• Anderson H R, Stitt A W, Gardiner T A, Archer D B. Stereological estimation of Weibel-Palade bodies in the retinal vasculature of normal and diabetic dogs. Curr Eye Res 1994; 13: 705–710
   PubMed Web of Science ®Google Scholar
• Anderson H R, Stitt A W, Gardiner T A, Archer D B. Diabetic retinopathy: morphometric analysis of basement membrane thickening of capillaries in different retinal layers within arterial and venous environments. Br J Ophthalmol 1995; 79: 1120–1123
   PubMed Web of Science ®Google Scholar
• Antonetti D A, Lieth E, Barber A J, Gardner T W. Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol 1999; 14: 240–248
   PubMedGoogle Scholar
• Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97: 512–523
   PubMed Web of Science ®Google Scholar
• Ashton N. Arteriolar involvement in diabetic retinopathy. Br J Ophthalmol 1953; 37: 282–292
   PubMed Web of Science ®Google Scholar
• Ashton N. Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973. Br J Ophthalmol 1974; 58: 344–366
   PubMed Web of Science ®Google Scholar
• Ballantyne A J, Loewenstein A. Diseases of the retina: the pathology of diabetic retinopathy. Trans Ophthalmol Soc UK 1943; 63: 95–115
   Google Scholar
• Baskin E, Balkanci F, Cekirge S, Sener C, Saatci U. Renal vascular abnormalities in Bardet-Biedl syndrome. Pediatr Nephrol 1999; 13: 787–789
   Google Scholar
• Beltramo E, Pomero F, Allione A, D'Alu F, Ponte E, Porta M. Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia 2002; 45: 416–419
   Google Scholar
• Benjamin L E, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by pdgf-b and vegf. Development 1998; 125: 1591–1598
   PubMed Web of Science ®Google Scholar
• Bjarnegard M, Enge M, Norlin J, Gustafsdottir S, Fredriksson S, Abramsson A, Takemoto M, Gustafsson E, Fassler R, Betsholtz C. Endothelium-specific ablation of pdgfb leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 2004; 131: 1847–1857
   PubMed Web of Science ®Google Scholar
• Boyd-White J, Williams J C, Jr. Effect of cross-linking on matrix permeability: a model for age-modified basement membranes. Diabetes 1996; 45: 348–353
   Google Scholar
• Bresnick G H, Davis M D, Myers F L, de Venecia G. Clinicopathologic correlations in diabetic retinopathy, II: clinical and histologic appearances of retinal capillary microaneurysms. Arch Ophthalmol 1977; 95: 1215–1220
   PubMedGoogle Scholar
• Chakravarthy U, Gardiner T A. Endothelium-derived agents in pericyte function/dysfunction. Prog Retin Eye Res 1999; 18: 511–527
   Google Scholar
• Chen J, Brodsky S V, Goligorsky D M, Hampel D J, Li H, Gross S S, Goligorsky M S. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res 2002; 90: 1290–1298
   PubMed Web of Science ®Google Scholar
• Chibber R, Molinatti P A, Wong J S, Mirlees D, Kohner E M. The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes 1994; 43: 758–763
   PubMed Web of Science ®Google Scholar
• Chowdhury T A, Hopkins D, Dodson P M, Vafidis G C. The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?. Eye 2002; 16: 689–693
   PubMed Web of Science ®Google Scholar
• Cogan D G, Kuwabara T. The mural cell in perspective. Arch Ophthalmol 1967; 78: 133–139
   PubMedGoogle Scholar
• Coles W H. Hypertension and retinal vessels. Heart Dis Stroke 1994; 3: 304–308
   Google Scholar
• Cox O T, Simpson D A, Stitt A W, Gardiner T A. Sources of pdgf expression in murine retina and the effect of short-term diabetes. Mol Vis 2003; 9: 665–672
   PubMed Web of Science ®Google Scholar
• Curtis T M, Major E H, Trimble E R, Scholfield C N. Diabetes-induced activation of protein kinase c inhibits store-operated Ca2 + uptake in rat retinal microvascular smooth muscle. Diabetologia 2003; 46: 1252–1259
   Google Scholar
• Curtis T M, Scholfield C N. The role of lipids and protein kinase cs in the pathogenesis of diabetic retinopathy. Diabetes Metab Res Rev 2004; 20: 28–43
   PubMed Web of Science ®Google Scholar
• Darland D C, Massingham L J, Smith S R, Piek E, Saint-Geniez M, D'Amore P A. Pericyte production of cell-associated vegf is differentiation-dependent and is associated with endothelial survival. Dev Biol 2003; 264: 275–288
   PubMed Web of Science ®Google Scholar
• DCCT. Hypoglycemia in the diabetes control and complications trial: the diabetes control and complications trial research group. Diabetes 1993; 46: 271–286
   Google Scholar
• Engerman R L, Kern T S. Experimental galactosemia produces diabetic-like retinopathy. Diabetes 1984; 33: 97–100
   PubMed Web of Science ®Google Scholar
• Engerman R L, Kern T S. Retinopathy in animal models of diabetes. Diabetes Metab Rev 1995; 11: 109–120
   PubMed Web of Science ®Google Scholar
• Fong D S, Sharza M, Chen W, Paschal J F, Ariyasu R G, Lee P P. Vision loss among diabetics in a group model health maintenance organization (HMO). Am J Ophthalmol 2002; 133: 236–241
   PubMed Web of Science ®Google Scholar
• Fong D S, Aiello L, Gardner T W, King G L, Blankenship G, Cavallerano J D, Ferris F L, 3rd, Klein R. Retinopathy in diabetes. Diabetes Care 2004; 27(1)S84–S87, Suppl
   PubMedGoogle Scholar
• Fruttiger M. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 2002; 43: 522–527
   PubMed Web of Science ®Google Scholar
• Funk R H. Blood supply of the retina. Ophthalmic Res 1997; 29: 320–325
   PubMed Web of Science ®Google Scholar
• Gardiner T A, Stitt A W, Anderson H R, Archer D B. Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br J Ophthalmol 1994; 78: 54–60
   PubMed Web of Science ®Google Scholar
• Gardiner T A, Anderson H R, Stitt A W. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol 2003; 201: 328–333
   PubMed Web of Science ®Google Scholar
• Gardiner T A, Gibson D S, de Gooyer T E, de la Cruz V F, McDonald D M, Stitt A W. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol 2005; 166: 637–644
   PubMed Web of Science ®Google Scholar
• Gardner T W, Antonetti D A, Barber A J, LaNoue K F, Nakamura M. New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets. Diabetes Technol Ther 2000; 2: 601–608
   PubMedGoogle Scholar
• Garner A, Ashton N, Tripathi R, Kohner E M, Bulpitt C J, Dollery C T. Pathogenesis of hypertensive retinopathy: an experimental study in the monkey. Br J Ophthalmol 1975; 59: 3–44
   PubMed Web of Science ®Google Scholar
• Garner A. Histopathology of diabetic retinopathy in man. Eye 1993; 7: 250–253, Pt 2
   PubMed Web of Science ®Google Scholar
• Grunwald J E, Riva C E, Brucker A J, Sinclair S H, Petrig B L. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology 1984; 91: 1447–1452
   PubMed Web of Science ®Google Scholar
• Grunwald J E, Riva C E, Petrig B L, Sinclair S H, Brucker A J. Effect of pure O2-breathing on retinal blood flow in normals and in patients with background diabetic retinopathy. Curr Eye Res 1984; 3: 239–241
   PubMed Web of Science ®Google Scholar
• Grunwald J E, Riva C E, Baine J, Brucker A J. Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci 1992; 33: 356–363
   PubMed Web of Science ®Google Scholar
• Hammes H P, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002; 51: 3107–3112
   PubMed Web of Science ®Google Scholar
• Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37: 614–636
   PubMed Web of Science ®Google Scholar
• Hoffmann J, Feng Y, vom Hagen F, Hillenbrand A, Lin J, Erber R, Vajkoczy P, Gourzoulidou E, Waldmann H, Giannis A, Wolburg H, Shani M, Jaeger V, Weich H A, Preissner K T, Hoffmann S, Deutsch U, Hammes H P. Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. FASEB J 2005; 19: 2035–2036
   Google Scholar
• Hohman T C, Nishimura C, Robison W G, Jr. Aldose reductase and polyol in cultured pericytes of human retinal capillaries. Exp Eye Res 1989; 48: 55–60
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Uyama M, Asayama K. Occlusive thromboaortopathy (takayasu's disease): cervical arterial stenoses, retinal arterial pressure, retinal microaneurysms and prognosis. Stroke 1983; 14: 730–735
   Google Scholar
• Kador P F, Akagi Y, Terubayashi H, Wyman M, Kinoshita J H. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol 1988; 106: 1099–1102
   PubMedGoogle Scholar
• Kador P F, Takahashi Y, Wyman M, Ferris F, 3rd. Diabeteslike proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 1995; 113: 352–354
   PubMed Web of Science ®Google Scholar
• Kalfa T A, Gerritsen M E, Carlson E C, Binstock A J, Tsilibary E C. Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci 1995; 36: 2358–2367
   Google Scholar
• Kern T S, Engerman R L. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curr Eye Res 1994; 13: 863–867
   PubMed Web of Science ®Google Scholar
• Kern T S, Engerman R L. Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp Eye Res 1995; 60: 545–549
   PubMed Web of Science ®Google Scholar
• Kern T S, Engerman R L. A mouse model of diabetic retinopathy. Arch Ophthalmol 1996; 114: 986–990
   PubMed Web of Science ®Google Scholar
• King G L, Goodman A D, Buzney S, Moses A, Kahn C R. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 1985; 75: 1028–1036
   PubMed Web of Science ®Google Scholar
• Klein R, Klein B E, Moss S E. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992; 15: 1875–1891
   PubMed Web of Science ®Google Scholar
• Kohner E M, Dollery C T, Paterson J W, Oakley N W. Arterial fluorescein studies in diabetic retinopathy. Diabetes 1967; 16: 1–10
   Google Scholar
• Kohner E M, Dollery C T. Fluorescein angiography of the fundus in diabetic retinopathy. Br Med Bull 1970; 26: 166–170
   Google Scholar
• Kohner E M, Henkind P. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 1970; 69: 403–414
   PubMed Web of Science ®Google Scholar
• Kohner E M, Patel V, Rassam S M. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 1995; 44: 603–607
   PubMed Web of Science ®Google Scholar
• Kristinsson J K, Gottfredsdottir M S, Stefansson E. Retinal vessel dilatation and elongation precedes diabetic macular edema. Br J Ophthalmol 1997; 81: 274–278
   PubMed Web of Science ®Google Scholar
• Kuwabara T, Cogan D G. Studies of retinal vascular patterns. Arch Ophthalmol 1960; 64: 124–131
   Google Scholar
• Kuwabara T, Cogan D G. Retinal vascular patterns, Vii: acellular change. Invest Ophthalmol 1965; 4: 1049–1064
   Google Scholar
• Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom H C, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C. Endothelial pdgf-b retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 2003; 17: 1835–1840
   PubMedGoogle Scholar
• Linskens M H, Harley C B, West M D, Campisi J, Hayflick L. Replicative senescence and cell death. Science 1995; 267: 17
   PubMedGoogle Scholar
• Ljubimov A V, Burgeson R E, Butkowski R J, Couchman J R, Zardi L, Ninomiya Y, Sado Y, Huang Z S, Nesburn A B, Kenney M C. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 1996; 44: 1469–1479
   PubMed Web of Science ®Google Scholar
• Miller S A, Stevens T S, de Venecia G. De novo lesions in presumed ocular histoplasmosis-like syndrome. Br J Ophthalmol 1976; 60: 700–712
   Google Scholar
• Miyamoto K, Ogura Y. Pathogenetic potential of leukocytes in diabetic retinopathy. Semin Ophthalmol 1999; 14: 233–239
   PubMedGoogle Scholar
• Mizutani M, Kern T S, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 1996; 97: 2883–2890
   PubMed Web of Science ®Google Scholar
• Moser L A, Simpson D E, Young D D. Retinal macroaneurysms: the natural history in four patients. Optom Vis Sci 1989; 66: 877–883
   Google Scholar
• Mott J D, Khalifah R G, Nagase H, Shield C F, 3rd, Hudson J K, Hudson B G. Nonenzymatic glycation of type iv collagen and matrix metalloproteinase susceptibility. Kidney Int 1997; 52: 1302–1312
   PubMed Web of Science ®Google Scholar
• Neuenschwander H, Julia C, Wyman M, Kador P F. Endothelial changes in galactose-fed dogs. Curr Eye Res 1995; 14: 319–322
   PubMed Web of Science ®Google Scholar
• Norton E W. Doyne memorial lecture, 1981: Fluorescein angiography, twenty years later. Trans Ophthalmol Soc U K 1981; 101: 229–233, Pt 2
   Google Scholar
• Padayatti P S, Jiang C, Glomb M A, Uchida K, Nagaraj R H. High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells. Curr Eye Res 2001; 23: 106–115
   PubMed Web of Science ®Google Scholar
• Petrovic V, Bhisitkul R B. Lasers and diabetic retinopathy: the art of gentle destruction. Diabetes Technol Ther 1999; 1: 177–187
   PubMedGoogle Scholar
• Pournaras C J, Riva C E, Tsacopoulos M, Strommer K. Diffusion of O2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res 1989; 49: 347–360
   PubMedGoogle Scholar
• Provis J M. Development of the primate retinal vasculature. Prog Retinal Eye Res 2001; 20: 799–821
   PubMed Web of Science ®Google Scholar
• Robison W G, Jr., Kador P F, Akagi Y, Kinoshita J H, Gonzalez R, Dvornik D. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Diabetes 1986; 35: 295–299
   PubMedGoogle Scholar
• Robison W G, Jr., Nagata M, Laver N, Hohman T C, Kinoshita J H. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci 1989; 30: 2285–2292
   PubMed Web of Science ®Google Scholar
• Roodhooft J M. Leading causes of blindness worldwide. Bull Soc Belge Ophtalmol 2002; 483: 19–25
   Google Scholar
• Roy S, Maiello M, Lorenzi M. Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest 1994; 93: 438–442
   Google Scholar
• Saint-Geniez M, D'Amore P A. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol 2004; 48: 1045–1058
   PubMed Web of Science ®Google Scholar
• Schmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 1999; 42: 387–405
   PubMed Web of Science ®Google Scholar
• Sharma N K, Gardiner T A, Archer D B. A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol 1985; 100: 51–60
   PubMed Web of Science ®Google Scholar
• Spranger J, Pfeiffer A F. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2001; 109: S438–S450
   PubMed Web of Science ®Google Scholar
• Srivastava S, Ramana K V, Tammali R, Srivastava S K, Bhatnagar A. Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes 2006; 55: 901–910
   PubMed Web of Science ®Google Scholar
• Stitt A W, Anderson H R, Gardiner T A, Archer D B. Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br J Ophthalmol 1994; 78: 133–137
   PubMed Web of Science ®Google Scholar
• Stitt A W, Gardiner T A, Archer D B. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol 1995; 79: 362–367
   PubMed Web of Science ®Google Scholar
• Stitt A W, Li Y M, Gardiner T A, Bucala R, Archer D B, Vlassara H. Advanced glycation end products (ages) co-localize with age receptors in the retinal vasculature of diabetic and of age-infused rats. Am J Pathol 1997; 150: 523–531
   PubMed Web of Science ®Google Scholar
• Stitt A W, Simpson D A, Boocock C, Gardiner T A, Murphy G M, Archer D B. Expression of vascular endothelial growth factor (vegf) and its receptors is regulated in eyes with intra-ocular tumours. J Pathol 1998; 186: 306–312
   PubMedGoogle Scholar
• Stitt A W, Gardiner T A, Alderson N L, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski A S, Chachich M, Baynes J W, Thorpe S R, Anderson N L. The age inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002; 51: 2826–2832
   PubMed Web of Science ®Google Scholar
• Stitt A W, Hughes S J, Canning P, Lynch O, Cox O, Frizzell N, Thorpe S R, Cotter T G, Curtis T M, Gardiner T A. Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia 2004; 47: 1735–1746
   Google Scholar
• Sundberg C, Kowanetz M, Brown L F, Detmar M, Dvorak H F. Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest 2002; 82: 387–401
   PubMed Web of Science ®Google Scholar
• Tolentino M J, Miller J W, Gragoudas E S, Jakobiec F A, Flynn E, Chatzistefanou K, Ferrara N, Adamis A P. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996; 103: 1820–1828
   PubMed Web of Science ®Google Scholar
• Tzekov R, Arden G B. The electroretinogram in diabetic retinopathy. Surv Ophthalmol 1999; 44: 53–60
   PubMed Web of Science ®Google Scholar
• Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, Honda Y, Wiegand S J, Yancopoulos G D, Nishikawa S. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 2002; 110: 1619–1628
   PubMed Web of Science ®Google Scholar
• UKPDS. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (ukpds 34). UK prospective diabetes study (UKPDS) group. Lancet 1998; 352: 854–865
   PubMed Web of Science ®Google Scholar
• vom Hagen F, Feng Y, Hillenbrand A, Hoffmann S, Shani M, Deutsch U, Hammes H P. Early loss of arteriolar smooth muscle cells: more than just a pericyte loss in diabetic retinopathy. Exp Clin Endocrinol Diabetes 2005; 113: 573–576
   PubMedGoogle Scholar
• Wilkinson-Berka J L, Babic S, De Gooyer T, Stitt A W, Jaworski K, Ong L G, Kelly D J, Gilbert R E. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. Am J Pathol 2004; 164: 1263–1273
   Google Scholar
• Wise G N. Arteriosclerosis secondary to retinal vein obstruction. Trans Am Ophthalmol Soc 1958; 56: 361–380, discussion 380–362
   Google Scholar
• Wong T Y, McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 2005; 73–74: 57–70
   PubMed Web of Science ®Google Scholar
• Yanoff M. Diabetic retinopathy. N Engl J Med 1966; 274: 1344–1349
   Google Scholar
• Yanoff M. Ocular pathology of diabetes mellitus. Am J Ophthalmol 1969; 67: 21–38
   PubMed Web of Science ®Google Scholar